Printer Friendly
The Free Library
14,694,658 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Gliomas topic

Subtopics (14)

 

Articles

1-80 out of 80 article(s)
Title Author Type Date Words
Gene mutation 'key to glioma brain cancer growth'. Nov 23, 2009 348
Agios Publishes Groundbreaking Research in Nature Uncovering the New Role of IDH1 Gene Mutation in Brain Cancer. Nov 23, 2009 1183
ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 Demonstrating Significant Increase in Tumor-Free Progression in Patients with Brain Cancer. Oct 27, 2009 1127
Data Presented on Oncophage[R] Cancer Vaccine in Recurrent Glioma at SNO 2009. Oct 26, 2009 1019
TransMolecular's 131I-TM601 Shown to Improve Survival in Recurrent Malignant Glioma. Clinical report Oct 23, 2009 692
Exercise in adolescence may cut brain tumor risk. Oct 21, 2009 408
Angiochem's ANG1005 Demonstrates Safety and Efficacy in Phase 1/2 Brain Cancer Studies. Oct 19, 2009 1096
ACTIVE teenagers may be protected [...]. Oct 12, 2009 138
Exercise in adolescence may cut brain tumor risk. Oct 12, 2009 406
Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics' Oncophage[R] Cancer Vaccine in Newly Diagnosed Glioma. Aug 12, 2009 829
United States : Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics Oncophage[R] Cancer Vaccine in Newly Diagnosed Glioma. Aug 12, 2009 254
Antigenics Announces Expansion of Investigator-Sponsored Study for Glioma. Jun 25, 2009 1066
ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial. Jun 4, 2009 1107
Neural stem cells may give rise to brain cancer. Jun 2, 2009 544
TransMolecular Presents New Data Highlighting the Anti-angiogenic and Tumor-targeting Properties of TM601 at ASCO Annual Meeting. Clinical report Jun 1, 2009 956
Clinical Data from Trial of ImmunoCellular Therapeutics' Cancer Vaccine ICT-107 to Be Presented at ASCO 2009 Annual Meeting. May 26, 2009 570
FDA Grants Orphan Drug Designation to Oncophage for the Treatment of Glioma. Apr 29, 2009 843
Eisai and Nobelpharma Sign License Agreement for GLIADEL(R) WAFER in Japan. Apr 6, 2009 711
AngioChem's ANG1005 Shows Promise In the Treatment of Brain Cancers. Mar 19, 2009 786
Antigenics' Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Brain Cancer. Mar 12, 2009 748
A Senior Cancer Researcher Joins PhytoMedical on Heels of Company's Successful Preclinical Study on Human Brain Cancer. Feb 26, 2009 1161
Scientists link two gene mutations to most common brain cancers. Feb 19, 2009 353
PhytoMedical's Patented Anti-Cancer Compound Eradicates Tumor in Successful In-Vivo Tests against Human Brain Cancer. Feb 3, 2009 1413
Burzynski Research Institute Partners with Premier Research to Manage Phase III Clinical Study of Children with Newly-Diagnosed Diffuse Intrinsic Brainstem Glioma. Jan 26, 2009 615
Burzynski Research Institute Gets SPA Clearance from the FDA to Initiate Pivotal Phase III Trial of Combination Antineoplaston Therapy and Radiation Therapy. Jan 13, 2009 663
TransMolecular Receives Orphan Drug Designation for 131I-TM601 for the Treatment of Melanoma. Dec 22, 2008 767
Treatments promising long-term survival in brain tumour patients identified. Dec 4, 2008 415
U.S. FDA Grants Orphan Drug Designation for Burzynski Research Institute's Antineoplaston Treatment for Gliomas. Dec 2, 2008 607
Final Data From Phase 1 Investigator-Sponsored Trial of Oncophage[R] Cancer Vaccine in Glioma Presented at the Society for Neuro-Oncology's Annual Meeting. Nov 24, 2008 904
Burzynski Research Institute, Inc. (BRI) Presents Promising Phase II Data on Malignant Glioma. Nov 21, 2008 529
Thought Leaders from Burzynski Research Institute, Inc. Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas. Nov 20, 2008 885
Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer. Nov 3, 2008 1138
Dosing Initiated in TransMolecular's Phase 1/2 Clinical Trial for Intravenous Administration of (131)Iodine-TM601 in Patients with Recurrent Malignant Glioma. Sep 29, 2008 1086
Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors. Aug 19, 2008 1349
TransMolecular Presents Imaging and Pharmacokinetic Analysis of (131)Iodine-TM601 at Society for Nuclear Medicine Meeting. Jun 17, 2008 719
Updated CDX-110 Data in Glioblastoma Multiforme Presented at 44th Annual ASCO Annual Meeting. Jun 2, 2008 1352
Effects of boswellic acids on malignant glioma. Winking, M. Brief article Jun 1, 2008 298
TransMolecular Initiates Phase 1 Clinical Trial for Unlabeled TM601 in Recurrent Malignant Glioma. May 30, 2008 865
BioInitiative's Hardell Finds Evidence Linking Gliomas and Heavy Cell Phone Use. May 23, 2008 282
TransMolecular Receives Orphan Drug Designation for Non-radiolabeled TM601 for the Treatment of Malignant Glioma. Jan 7, 2008 668
TransMolecular Reports Positive Phase 2 Data from Study of (131)Iodine Radiolabeled TM-601 in Recurrent Glioma. Nov 19, 2007 898
TransMolecular Reports Positive Phase 1 Trial of (131)Iodine Radiolabeled TM-601 in Glioma. Oct 31, 2007 829
Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Conference news Oct 25, 2007 959
First Patient Registered in Investigator-Sponsored Phase 2 Trial of Antigenics' Oncophage Cancer Vaccine in Glioma. Oct 10, 2007 853
A Substantial Opportunity Exists for Second-Line Chemotherapy to Enter the Primary Brain Cancer Market. Jul 24, 2007 395
MGI PHARMA Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting. Jun 4, 2007 2682
The role of PET in the management of brain tumors. Spence, Alexander M.; Mankoff, David A.; Muzi, Mark Jun 1, 2007 7299
Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting. Apr 16, 2007 1014
Antiproliferative effects of mitraphylline, a pentacyclic oxindole alkaloid of Uncaria tomentosa on human glioma and neuroblastoma cell lines. Prado, E. Garcia; Gimenez, M.D. Garcia; De la Puerta Vazquez, R.; Sanchez, J.L. Espartero; Rodriguez Clinical report Apr 1, 2007 2354
Glioblastoma multiforme disguised as sarcoidosis: pitfalls in diagnosis. Weibel, Sandra Mar 1, 2007 481
Light Sciences Oncology Initiates Phase II Trial of Litx(TM) Therapy in Patients with Glioma. Feb 14, 2007 634
OFAC clears cancer drug for U.S. trials. Feb 1, 2007 310
Mixed glioneuronal tumors: recently described entities. Edgar, Mark A.; Rosenblum, Marc K. Clinical report Feb 1, 2007 3624
Mobile users '40pc more likely to get a tumour'. Jan 26, 2007 570
NEOPHARM Announces Presentation of Final Safety Data from Phase 1 Trial of CINTREDEKIN BESUDOTOX for Newly Diagnosed Malignant Glioma. Nov 20, 2006 1282
NEOPHARM Presents Updated CINTREDEKIN BESUDOTOX Phase I/II Median Survival Data at European Association of Neuro-Oncology (EANO) Meeting. Sep 18, 2006 1819
NEOPHARM Provides Update on Reimbursement Progress for CINTREDEKIN BESUDOTOX; Unique Coding Provided for Convection Enhanced Delivery. Aug 7, 2006 1775
NeoPharm Announces PRECISE Trial Update; Independent Data Monitoring Committee Recommends PRECISE Trial Continue to Final Efficacy Analysis. Jun 22, 2006 1912
Optimizing Catheter Positioning Improves Drug Distribution of Cintredekin Besudotox via Convection Enhanced Delivery. Apr 26, 2006 2107
NeoPharm's Cintredekin Besudotox Well-Tolerated in Newly Diagnosed Malignant Glioma Patients. Apr 25, 2006 1694
NeoPharm's Cintredekin Besudotox Continues to Show Evidence of Prolonged Overall Survival in Patients with Recurrent Glioblastoma Multiforme. Apr 24, 2006 2029
CombinatoRx Announces Discovery of Novel Synergistic Combination Leads for Glioblastoma; Data presented at AACR. Apr 3, 2006 741
Gliadel(R) Wafer Demonstrates Long-Term Survival Benefit for Patients with High-Grade Malignant Gliomas. Mar 8, 2006 944
MOBILES DON'T GIVE YOU BRAIN CANCER SAYS BIGGEST SURVEY EVER. Jan 20, 2006 308
NeoPharm, Inc. Announces PRECISE Trial Update. Dec 27, 2005 1771
NeoPharm Announces Completion of PRECISE Trial Enrollment as Per Special Protocol Assessment Agreement. Dec 9, 2005 1996
NeoPharm Announces Precise Trial Update. Nov 21, 2005 1914
NeoPharm Investigators Present Preliminary Phase I Data of Cintredekin Besudotox in the Treatment of Malignant Glioma at Initial Diagnosis. Oct 10, 2005 1169
Double balloon GliaSite in the management of recurrent glioblastoma multiforme. Meigooni, Ali Sep 1, 2005 951
Genetic mutations in brain tumors identified by scientists from Venter Institute, Ludwig Institute, and Johns Hopkins. Sep 1, 2005 554
Section on Pathology. (Abstracts of Scientific Posters). Dec 1, 2002 1512
Immunohistochemical analysis of p18INK4C and p14ARF protein expression in 117 oligodendrogliomas: correlation with tumor grade and clinical outcome. Korshunov, Andrey; Golanov, Andrey Jan 1, 2002 4877
Nasal glioma: A case report. Leu, Yi-Shing Jun 1, 2001 818
HAM56-Immunoreactive Macrophages in Untreated Infiltrating Gliomas. Cummings, Thomas J.; Hulette, Christine M.; Bigner, Sandra H.; Riggins, Gregory J.; McLendon, Roger May 1, 2001 2902
Radioactive antibodies on the mind. D.C. Brief Article Apr 21, 2001 244
Analysis of 2 Antiapoptotic Factors in Gliomas: bcl-2 Overexpression and p53 Mutations. Rodriguez-Pereira, C.; Suarez-Penaranda, J. M.; Barros, F.; Sobrido, M. J.; Vazquez-Salvado, M.; For Feb 1, 2001 5734
Nasal Glial Heterotopia. Kardon, David E. Dec 1, 2000 478
Combined Pleomorphic Xanthoastrocytoma-Ganglioglioma of the Cerebellum. Evans, Andrew J.; Fayaz, Imran; Cusimano, Michael D.; Laperriere, Norman; Bilbao, Juan M. Nov 1, 2000 2038
Somatix Receives U.S. Patent Covering Method For Treating Glioma. Jun 27, 1996 491
Cancer cells remain after tumor removal. Brief Article Oct 1, 1995 486

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles